SARS-CoV-2-specific immune response and the pathogenesis of COVID-19

E Gusev, A Sarapultsev, L Solomatina… - International journal of …, 2022 - mdpi.com
The review aims to consolidate research findings on the molecular mechanisms and
virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative …

Two years into the COVID-19 pandemic: lessons learned

SJR da Silva, JCF do Nascimento… - ACS infectious …, 2022 - ACS Publications
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible
and virulent human-infecting coronavirus that emerged in late December 2019 in Wuhan …

T cell metabolism in infection

JA Wik, BS Skålhegg - Frontiers in immunology, 2022 - frontiersin.org
T lymphocytes (T cells) are divided into two functionally different subgroups the CD4+ T
helper cells (Th) and the CD8+ cytotoxic T lymphocytes (CTL). Adequate CD4 and CD8 T …

A global picture: therapeutic perspectives for COVID-19

VP Chavda, C Kapadia, S Soni, R Prajapati… - …, 2022 - Taylor & Francis
The COVID-19 pandemic is a lethal virus outbreak by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …

Optimization of the SARS-CoV-2 ARTIC network V4 primers and whole genome sequencing protocol

AW Lambisia, KS Mohammed, TO Makori… - Frontiers in …, 2022 - frontiersin.org
Introduction The ARTIC Network's primer set and amplicon-based protocol is one of the most
widely used SARS-CoV-2 sequencing protocol. An update to the V3 primer set was released …

Clinical severity of SARS-CoV-2 omicron variant compared with delta among hospitalized COVID-19 patients in Belgium during autumn and winter season 2021 …

N Van Goethem, PYJ Chung, M Meurisse… - Viruses, 2022 - mdpi.com
This retrospective multi-center matched cohort study assessed the risk for severe COVID-19
(combination of severity indicators), intensive care unit (ICU) admission, and in-hospital …

[HTML][HTML] Herbal remedies, nutraceuticals, and dietary supplements for COVID-19 management: an update

VP Chavda, AB Patel, D Vihol, DD Vaghasiya… - Clinical Complementary …, 2022 - Elsevier
Currently, the world is facing a Coronavirus pandemic with a grave deficiency of specific
therapy for Coronavirus Disease (COVID-19). Moreover, scientists attempt to discover the …

SARS-CoV-2 variants and clinical outcomes: a systematic review

IR Mendiola-Pastrana, E Lopez-Ortiz… - Life, 2022 - mdpi.com
Background: From the start of the COVID-19 pandemic, new SARS-CoV-2 variants have
emerged that potentially affect transmissibility, severity, and immune evasion in infected …

COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies

I Polatoğlu, T Oncu‐Oner, I Dalman, S Ozdogan - MedComm, 2023 - Wiley Online Library
Abstract Coronavirus Disease‐19 (COVID‐19) is an infectious disease caused by severe
acute respiratory syndrome‐coronaviruses‐2 (SARS‐CoV‐2), a highly pathogenic and …

Spike protein mediated membrane fusion during SARS‐CoV‐2 infection

X Li, H Yuan, X Li, H Wang - Journal of Medical Virology, 2023 - Wiley Online Library
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
has posed a serious threat to public health and has quickly become a global concern. The …